Regadenoson Injection, Solution
Product Images NDC 0641-6253

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 0641-6253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regadenoson Structural Formula (Regadenoson Injection 1)

Regadenoson Structural Formula (Regadenoson Injection 1)
Chemical structure of Regadenoson, depicting its molecular components including a purine base with attached amine groups, ribose sugar, and an imidazole ring with additional functional groups. A water molecule (H2O) is indicated as part of the structure.*
FDA Label Image

Regadenoson Injection 0.4 mg Per 5 mL (0.08 mg/ml) Syringe Label (Regadenoson Injection 2)

Regadenoson Injection 0.4 mg Per 5 mL (0.08 mg/ml) Syringe Label (Regadenoson Injection 2)
Label for Regadenoson Injection, 0.4 mg per 5 mL (0.08 mg/mL) in a 5 mL single-dose pre-filled syringe by Hikma Pharmaceuticals USA Inc. Intended for intravenous use only, for pharmacologic stress. Includes barcode, lot, and expiration date fields.*
FDA Label Image

Regadenoson Carton (Regadenoson Injection 3)

Regadenoson Carton (Regadenoson Injection 3)
Packaging label for Regadenoson Injection 0.4 mg per 5 mL (0.08 mg/mL) intravenous solution, a pharmacologic stress agent supplied as a single-dose prefilled syringe. Labeler is Hikma Pharmaceuticals USA Inc. The label includes usage instructions for the syringe and storage conditions information.*
FDA Label Image

Representative Serialization Image (Regadenoson Injection 4)

Representative Serialization Image (Regadenoson Injection 4)
The label features a white rectangular background with a QR code on the left side. To the right, it displays GTIN, Serial Number (SN), Expiration Date (EXP), and Lot Number (LOT) information in black text, formatted as placeholders. The label pertains to Regadenoson injection, solution, at .08 mg/mL, distributed by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.